Class Settlement Approved in Generic Wellbutrin MDL

Federal multidistrict consumer litigation by plaintiffs alleging certain generic versions of the Wellbutrin antidepressant do not work as well as the branded drug came to a close July 2 as a federal trial court in Pennsylvania certified a settlement class and gave final approval to the class settlement.

The U.S. District Court for the Eastern District of Pennsylvania tentatively approved the injunctive relief settlement in February (13 CLASS 155, 2/10/12).

Bupropion hydrochloride is the active ingredient in Wellbutrin and several generic antidepressants. Defendants Impax Laboratories Inc. and Teva Pharmaceuticals USA manufacture and sell a generic bupropion hydrochloride XL ...